Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

This Therapy Improves Survival in Testicular DLBCL

Leuk Lymphoma; ePub 2017 May 9; Ho, Dabaja, et al

Publish date:: May 24, 2017

Testicular radiation is linked with improved survival in patients with testicular diffuse large B-cell lymphoma (DLBCL), according to a study involving 120 individuals.

Participants had Stage I-IV testicular DLBCL and were treated between 1964 and 2015. Investigators looked at how testicular radiation and prophylactic central nervous system (CNS) therapies each impacted overall, progression free, testicular relapse free, and CNS relapse free survival. Among the results:

7 in every 10 received radiation therapy.
53% received anthracyclines and rituximab.
6 in every 10 received CNS prophylaxis.
Univariate analysis showed that radiation therapy was linked with improved testicular relapse free and progression free survival.
On multivariate analysis, radiation was significantly linked with improved overall and progression free survival.
The progression free survival benefit persisted in patients receiving anthracyclines and rituximab.
CNS prophylaxis was not significant on multivariate analysis.

Citation:

Ho J, Dabaja B, Milgrom S, et al. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma. [Published online ahead of print May 9, 2017]. Leuk Lymphoma. doi:10.1080/10428194.2017.1312381.

This Week's Must Reads

Phase II Trial of DNA Vaccine Encoding PAP in Patients with PCa ,

Utilization of Surgery for Post-prostatectomy Incontinence,

Claims Analysis of Advanced PCa Treatment Costs and Resource Use,

Testosterone Therapy Doesn't Increase Prostate Cancer Risk,

Clinical Outcomes in Cyclin-dependent Kinase 12 Mutant Advanced PCa,

Must Reads in Lymphoma & Plasma Cell Disorders

Cardiac assessment before doxorubicin treatment , Enns DL et al. Mayo Clin Proc Innov Qual Outcomes. 2018 Aug 3;2(3):277-85

Long-term ibrutinib data in older patients, Barr PM et al. Haematologica. 2018;103(9):1502-10

Outcomes Post-AlloSCT in DHL/DEL Lymphomas, Biol Blood Marrow Transplant; ePub 2017 Nov 28; Herrera, et al

Anthracycline-Related CV Dysfunction Evaluated, Cancer; ePub 2017 Nov 7; Armenian, Mertens, et al

Adcetris Approved for Primary Cutaneous ALCL, FDA news release; 2017 Nov 9